ask="41.40"
ask_size="500"
average_daily_volume="359387"
bid="37.89"
bid_size="100"
book_value="6.43"
change="+0.62"
change_from_200_day_moving_average="9.85"
change_from_50_day_moving_average="5.35"
change_from_52_week_high="-1.06"
change_From_52_week_low="28.09"
change_in_percent="+1.52%"
close="41.36"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.64"
ebitda="-71.00M"
eps_estimate_current_year="-3.49"
eps_estimate_next_quarter="-0.82"
eps_estimate_next_year="-4.25"
ex_dividend_date="N/A"
float_shares="23554000"
high="41.71"
high_52_weeks="42.42"
last_trade_date="3/17/2017"
last_trade_price="41.36"
last_trade_size="31211"
last_trade_time="4:00pm"
low="39.29"
low_52_weeks="13.27"
market_capitalization="1.37B"
moving_average_200_day="31.51"
moving_average_50_day="36.01"
name="Blueprint Medicines Corporation"
notes="N/A"
one_year_target_price="43.83"
open="40.31"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+31.26%"
percent_change_from_50_day_moving_average="+14.86%"
percent_change_from_52_week_high="-2.50%"
percent_change_from_52_week_low="+211.68%"
previous_close="40.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.33"
price_per_sales="48.59"
revenue="27.77M"
shares_outstanding="33123000"
short_ratio="8.43"
stock_exchange="NMS"
symbol="BPMC"
volume="505554"
weeks_range_52="13.27 - 42.42"
